Camilo Albornoz Carranza
About Camilo Albornoz Carranza
Camilo Albornoz Carranza is an Assay and Data Management Scientist at BenevolentAI in London, with a background in neuroscience from The University of Manchester.
Current Work at BenevolentAI
Camilo Albornoz Carranza currently works as an Assay and Data Management Scientist at BenevolentAI in London, England, United Kingdom. At BenevolentAI, he is involved in harnessing computational and experimental methods to advance the field of neuroscience and pharmacology. His role likely focuses on managing and interpreting complex data to support scientific discoveries and innovative solutions in biomedical research.
Previous Experience at iGEM Foundation
Camilo Albornoz Carranza was an iGEM Team Member for The University of Manchester from 2018 to 2019. During this period, he contributed to the global synthetic biology competition, iGEM, where his team successfully earned a gold medal in 2019. This experience provided him with valuable teamwork and project management skills, as well as practical experience in synthetic biology and genetic engineering.
Educational Background in Neuroscience
Camilo Albornoz Carranza studied at The University of Manchester from 2017 to 2021, where he obtained a Master of Science (MS) degree in Neuroscience. His academic work included in-depth research on the role of tumour necrosis factor-stimulated gene-6 (TSG-6) and mesenchymal stem cells in ischaemic stroke. This program helped him cultivate a strong foundation in both theoretical knowledge and practical laboratory skills relevant to neuroscience.
High School Education
Camilo Albornoz Carranza completed his high school education at Colegio Anglo Colombiano, graduating with a High School Diploma. He attended this institution from 2002 to 2016. His formative years at Colegio Anglo Colombiano provided a solid educational foundation that paved the way for his advanced studies in neuroscience.
UK Home Office Personal Licence
Camilo Albornoz Carranza holds a UK Home Office Personal Licence (PIL A, B, and C), which authorizes him to conduct in vivo experiments with rats and mice. This licensure indicates his proficiency and compliance with ethical standards in animal research, a crucial component in biomedical sciences and pharmacology.
Research Focus and Skills
Camilo Albornoz Carranza combines his experimental knowledge with computational skills to drive new discoveries in neuroscience and pharmacology. His research has included studying the effects of mesenchymal stem cells and TSG-6 in stroke, utilizing both hands-on laboratory techniques and data-driven approaches. This skill set positions him well to contribute to the cutting-edge intersection of experimental and computational research.